FRI0182 Non-biologics disease modifying anti-rheumatic drugs (nbdmards) and biologics agents acquisition and adherence among french rheumatoid arthritis patients in real life population: results from a cross-sectional study

2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A433.2-A433
Author(s):  
C. Deslandre ◽  
J.-C. Balblanc ◽  
E. Desfleurs ◽  
J. Antheaume ◽  
P. Dieudé
2017 ◽  
Vol 37 (10) ◽  
pp. 1709-1718 ◽  
Author(s):  
Natalia Mena-Vazquez ◽  
Sara Manrique-Arija ◽  
Lucía Yunquera-Romero ◽  
Inmaculada Ureña-Garnica ◽  
Marta Rojas-Gimenez ◽  
...  

2015 ◽  
Vol 37 (2) ◽  
pp. 207-213 ◽  
Author(s):  
Lorena Michele Brennan-Bourdon ◽  
Ulises De la Cruz-Mosso ◽  
Zyanya Reyes-Castillo ◽  
Gloria Esther Martínez-Bonilla ◽  
María Guadalupe Ramírez-Dueñas ◽  
...  

2020 ◽  
Vol 13 (8) ◽  
Author(s):  
Jaleh Naderi ◽  
Arvind Chopra ◽  
Renu Relwani

Background: Much research has been done on reproductive tract infections (RTIs), but no study exists about RTIs among rheumatoid arthritis women. Objectives: This study investigated the prevalence and risk factors of RTIs among reproductive-aged women with rheumatoid arthritis in Pune, India. Methods: This clinical-based, cross-sectional study enrolled a sample of 400 consenting Indian women aged 15 -49 years with a history of at least three months’ rheumatoid arthritis referring to a popular community center. Patients were interviewed comprehensively using previously validated relevant questionnaires. Women underwent gynecological examinations and vaginal smears (wet mount) by a microbiologist to diagnose candidiasis, bacterial vaginosis, and trichomoniasis. Syphilis serological testing was performed for the study population. Results: The prevalence obtained was 39.3%. Infection with bacterial vaginosis was 32.0%, Candidiasis 6.5%, and trichomoniasis 0.8%. Syphilis seroconversion was not observed. Adjusting for confounding factors in logistic regression showed that four factors remained significant, including age under 30 years [AOR: 2.4, 95% CI: 1.2 - 4.9], living in a crowded and small one-room house [AOR: 2.5, 95% CI: 1.2 - 5.1] , improper linen for menstruation bleeding [AOR: 1.9, 95% CI: 1.1 - 3.3], and oral disease-modifying anti-rheumatic drugs [AOR: 3.96, 95% CI: 1.9 - 7.9]. Conclusions: This study demonstrated a large burden of RTIs in women suffering from rheumatoid arthritis. Regular screening algorithms for RTIs are urgently required to prevent neglect and improve overall standard care in rheumatology practice. The presence of an oral disease-modifying anti-rheumatic drug as a risk factor shows that more investigation is necessary in this case.


Author(s):  
Khaled Algohani ◽  
Muhannad Althobaiti ◽  
Sanad Alshammari ◽  
Fahad Alnahari ◽  
Ali Aldahhasi ◽  
...  

2018 ◽  
Vol 68 (12) ◽  
pp. 2987-2991
Author(s):  
Cristina Iordache ◽  
Bogdan Vascu ◽  
Eugen Ancuta ◽  
Rodica Chirieac ◽  
Cristina Pomirleanu ◽  
...  

Temporomandibular joint (TMJ) is commonly involved in various immune-mediated rheumatic disorders accounting for significant disability and impaired quality of life. The aim of our study was to assess inflammatory and immune parameters in patients with TMJ arthritis related to rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) and to identify potential relation with severity and dysfunction of TMJ pathology. We performed a cross-sectional study in a cohort of 433 consecutive RA, 32 JIA, 258 AS, and 103 PsA. Only patients presenting with clinically significant TMJ involvement (273) related to their rheumatic condition were included in the final analysis. TMJ involvement is traditionally described in chronic inflammatory rheumatic disorders, particularly in patients with higher levels of inflammation as detected in rheumatoid arthritis and psoriatic arthritis. Disease activity and severity, as well as biological and positive serological assessments (rheumatoid factor, anti-cyclic citrullinated peptide, IL-1) remain significant determinants of the severity of TMJ arthritis.


Sign in / Sign up

Export Citation Format

Share Document